Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Parenteral nutrition practice in the United States: A cross-sectional survey with gap analysis.

JPEN. Journal of parenteral and enteral nutrition·2026

Same author

Parenteral Nutrition Prescribing and Order Review Safety Study: The Need for Pharmacist Intervention.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2020

Same author

A.S.P.E.N. Standards for Nutrition Support: Home and Alternate Site Care.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2014

Same author

A.S.P.E.N. ethics position paper.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2010

Same author

Standards of practice for nutrition support pharmacists.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2008

Same author

Standards for specialized nutrition support for adult residents of long-term care facilities.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2006

Search research articles

Related Experiment Video

Updated: May 25, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Pharmacist specialty certification.

Sharon M Durfee¹

¹Poudre Infusion Therapy, LLC, Fort Collins, Colorado, USA. sharon.durfee@columbinehealth.com

JPEN. Journal of Parenteral and Enteral Nutrition

|January 26, 2012

Summary

This summary is machine-generated.

Pharmacists play a key role in nutrition support, managing complex parenteral nutrition. This article outlines the certification options available for pharmacists specializing in this critical area.

More Related Videos

HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis

HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis

Published on: November 11, 2022

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Experiment Videos

Last Updated: May 25, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis

HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis

Published on: November 11, 2022

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Area of Science:

Pharmacy
Clinical Nutrition
Specialty Pharmacy Practice

Background:

Nutrition support is a specialized area within pharmacy practice.
It involves collaboration with prescribers and oversight of parenteral nutrition (PN) formulations.
Pharmacists are integral to ensuring the safe and effective delivery of PN.

Purpose of the Study:

To define the scope of practice for pharmacists in nutrition support.
To highlight the importance of specialized certification for these pharmacists.
To provide an overview of available certification pathways in this pharmacy specialty.

Main Methods:

Review of current literature and professional guidelines related to nutrition support pharmacy.
Identification of key responsibilities including order review and compounding oversight.
Analysis of existing pharmacist certification options in the specialty.

Main Results:

Nutrition support pharmacy requires expertise in order review and complex PN formulation compounding.
Pharmacist involvement is crucial for optimizing patient outcomes in nutrition support.
Several certification options exist for pharmacists seeking to validate their expertise.

Conclusions:

Pharmacists specializing in nutrition support should pursue certification.
Certification enhances professional recognition and demonstrates competency in PN.
This article serves as a guide to available certification credentials for nutrition support pharmacists.